NAUT

NAUTILUS BIOTECHNOLOGY INC

NAUT·63909J108·US·Common Stock·Healthcare - Biotechnology-Activist

NAUT (NAUTILUS BIOTECHNOLOGY INC) is held by 45 institutional investors as of Q1 2026. Largest holders: VANGUARD CAPITAL MANAGEMENT LLC ($9.9M), MILLENNIUM MANAGEMENT LLC ($4.9M), GEODE CAPITAL MANAGEMENT, LLC ($2.3M). Net institutional sentiment: Mixed.

45
Holders
Avg rating(9 Elite)
$29.4M
Total Value
62% (51)
Fund Consensus
28 buying - 17 selling
NAUTSmart Money Verdict
View all
Held by 45 funds
9 elite
Who's Trading
ActivistABAH Bio Fund II, L.P.6.6%Jun 30, 2026
ActivistABAH Bio Fund II, L.P.9.2%Jun 4, 2026
InsiderPMPatel Sujal MBuy $65KMar 4, 2026
ActivistSPSujal Patel16.3%Mar 4, 2026
ActivistPMParag Mallick17.6%Mar 4, 2026
InsiderSKSuzuki KentaroBuy $6KNov 6, 2025
InsiderPMPatel Sujal MBuy $57KSep 8, 2025
InsiderPMPatel Sujal MBuy $79KSep 5, 2025
InsiderMBMurphy Matthew B.Buy $13KSep 4, 2025
ActivistPAPerceptive Advisors LLC10.1%Jun 24, 2025
13F: Insider & Congress:
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
New
2.5M$9.9M0.0%-21.58%
38
Increased
1.3M(+24.8%)$4.9M0.0%+69.28%
33
Increased
603,524(+7.6%)$2.3M0.0%-54.73%
28
Increased
390,768(+31.4%)$1.5M0.0%+3.68%
32
Increased
329,123(+15.3%)$1.3M0.0%-31.55%
29
Increased
319,882(+173.3%)$1.2M0.0%-15.13%
41
New
305,526$1.2M0.0%-21.58%
35
Increased
265,700(+2.2%)$1M0.0%+62.06%
26
Increased
216,270(+7.5%)$839,1280.0%-33.35%
18
Decreased
187,671(-0.9%)$728,1630.0%+13.17%
0
Unchanged
114,788$445,3770.0%+119.28%
0
Unchanged
107,011$415,2030.0%-46.11%
0
Increased
83,043(+36.5%)$322,2070.0%-7.52%
31
Decreased
79,623(-35.3%)$308,9370.0%+35.19%
0
Increased
73,325(+52.0%)$284,5010.0%-30.31%
33
Increased
63,147(+213.1%)$245,0100.0%-15.90%
25
Decreased
61,802(-70.1%)$239,7920.0%+49.07%
0
New
60,501$234,7440.0%-21.58%
32
Increased
49,503(+28.3%)$192,0720.0%-17.90%
19
Unchanged
49,449$189,8840.0%-29.22%
0

Showing 1-20 of 51

1 / 3

Other Healthcare stocks held by institutions

Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used